Onto Innovation Inc. — Form 10-Q Summary
Period: Fiscal second quarter ended June 26, 2021; six-month period ended the same date. The request metadata says “2019 Q2,” but the filing itself is for 2021 Q2.
Business context
Onto designs, manufactures, and supports process-control inspection, metrology, lithography, and software systems used by semiconductor and advanced-packaging manufacturers. It reports one operating segment.
Financial performance
Amounts below are in millions of dollars, except per-share data. Comparisons are with the corresponding 2020 period unless noted.
| Metric | Q2 2021 | Q2 2020 | First half 2021 | First half 2020 |
|---|---|---|---|---|
| Revenue | $193.4 | $134.9 | $362.7 | $274.9 |
| Gross profit | $105.5 | $71.6 | $195.9 | $134.2 |
| Gross margin | 54.5% | 53.0% | 54.0% | 48.8% |
| Operating income | $35.9 | $7.9 | $63.4 | $2.7 |
| Net income | $35.1 | $7.4 | $59.2 | $3.0 |
| Diluted EPS | $0.71 | $0.15 | $1.19 | $0.06 |
| Operating cash flow | Not presented for quarter | Not presented for quarter | $76.4 | $46.9 |
- Q2 revenue rose 43.3% year over year and 14.2% sequentially; first-half revenue grew 31.9% year over year. Management attributed sequential growth mainly to specialty-device markets, particularly RF and power customers, partly offset by lower advanced-node sales.
- First-half systems and software revenue increased to $304.4 million from $222.6 million, primarily reflecting more metrology and inspection units shipped. Parts growth reflected a larger installed base; service revenue was slightly lower year over year.
- Management attributed improved first-half gross margin mainly to the absence of $9.9 million of 2020 purchase-accounting inventory step-up charges and stronger product margins. Sequential Q2 margin improvement was attributed to product mix.
Cash, liquidity, and capital
- At June 26, cash and cash equivalents were $134.2 million and marketable securities were $276.6 million, totaling $410.8 million. Working capital was $678.5 million.
- First-half operating cash flow was $76.4 million. Investing activities used $76.4 million, including $26.8 million for the Inspectrology acquisition and $9.6 million of capital expenditures; financing activities used $3.3 million. Cash and cash equivalents ended the period at $134.2 million.
- Total liabilities were $216.9 million, including $133.2 million of current liabilities. The filing reports no borrowings; a securities-backed credit line had approximately $99.4 million available at a stated 1.8% rate and had not been used.
- The company said existing cash, securities, and credit availability should cover anticipated cash needs for the next 12 months. It had $100 million remaining under its share-repurchase authorization; no program repurchases were reported for the first half.
Outlook, risks, and unusual items
- The filing provides no specific revenue or earnings guidance. Management described the business as well-positioned financially but noted that future capital needs depend on revenue and investment decisions.
- U.S. export restrictions affected approximately $7.3 million of orders from China; Onto had applied for licenses and was awaiting responses. Further restrictions could affect China sales.
- Samsung Semiconductor represented 22% of first-half revenue and Taiwan Semiconductor Manufacturing Co. 16%, underscoring customer concentration.
- Management reported no material direct COVID-19 financial impact through the filing date, but warned that pandemic developments, supply-chain disruption, demand changes, and trade tensions could materially affect future results.
- Inspectrology was acquired for $27.0 million in cash, with a potential $10.0 million earnout. As of June 26, management did not believe earnout criteria would be met.
- A pending dispute with Optical Solutions was in discovery; management assessed the loss contingency as remote and did not expect a material financial impact. The company also disclosed customary intellectual-property indemnification obligations for which a maximum exposure could not be reasonably estimated.
- Disclosure controls were assessed as effective. Key risks include semiconductor-industry cyclicality, export controls, customer concentration, component availability, inventory forecasting, competition, cybersecurity, and acquisition integration.
Important facts for investors to verify
- Confirm the intended reporting period: the supplied filing is for Q2 2021, not Q2 2019.
- Track export-license decisions and the revenue impact of restricted China orders.
- Monitor customer concentration, especially Samsung and TSMC, and changes in orders or shipment timing.
- Assess whether stronger margins and cash generation persist as product mix and demand evolve.
- Review inventory levels, supply constraints, and the integration and performance of Inspectrology.